Tempo2 Trial Results and Implications for Minor Stroke Patients

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent trials presented at the European Stroke Organization Conference.

Show references: 

Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy 

Rationale and Design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III)

Colchicine for Prevention of Vascular Inflammation in Non-CardioEmbolic Stroke (CONVINCE)

Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Disclosures can be found at Neurology.org.